Shareholders of Saudi Pharmaceutical Industries and Medical Appliances Corp. (SPIMACO) approved the board’s recommendation to pay a cash dividend at 6% of capital, or SAR 0.60 a share, for 2021, during the ordinary general meeting (OGM) held on June 8, according to a bourse filing.
|
Dividend Details |
|
|
Current Capital |
SAR 1.2 bln |
|
Number of Shares |
120 mln |
|
Total Dividend |
SAR 72 mln |
|
Percentage of Capital |
6% (SAR 0.60 a share) |
|
Record Date |
June 8, 2022, shareholders registered with the Securities Depository Center (Edaa) by the close of trading on the second day after the OGM date |
|
Payment Date |
June 27, 2022 |
Shareholders also authorized the board of directors to pay interim dividends for 2022 on a semi-annual or quarterly basis. They further approved the business contracts, which will be inked with Arab Company for Drug Industries and Medical Appliances (ACDIMA), in which the board members Adel Kareem and Mohammed Khalil have indirect interests.
Karim serves as Chairman of ACDIMA, while Khalil is the Director General. The business and contracts are represented in a share purchase agreement, under which SPIMACO will acquire ACDIMA’s shares in CAD Middle East Pharmaceutical Industries for SAR 10.53 million, without preferential terms.
| Announcement | Ex-Dividend | Payment | Dividends (M Riyal) | Dividends * | Notes |
| 24/03/2022 | 08/06/2022 | 27/06/2022 | 72.00 | 0.60 | |
| 23/03/2021 | 30/05/2021 | 16/06/2021 | 120.00 | 1.00 | |
| 31/03/2020 | 14/05/2020 | 11/06/2020 | 60.00 | 0.50 | |
| 05/03/2019 | 02/04/2019 | 18/04/2019 | 120.00 | 1.00 | |
| 31/07/2018 | 30/08/2018 | 20/09/2018 | 60.00 | 0.50 | |
| 22/03/2018 | 19/04/2018 | 03/05/2018 | 120.00 | 1.00 | |
| 12/03/2017 | 16/04/2017 | 11/05/2017 | 120.00 | 1.00 | |
| 16/02/2016 | 03/04/2016 | 28/04/2016 | 120.00 | 1.00 | |
| 17/02/2015 | 23/04/2015 | 14/05/2015 | 180.00 | 1.50 | |
| 23/02/2014 | 17/04/2014 | 11/05/2014 | 78.44 | 0.65 |
| Consolidated cash dividend | Cash dividend per share (SAR) | * The stock price at the beginning of the period (SAR) | Return on the base price |
|---|---|---|---|
| Last 3 Financial years | 1.60 | 27.50 | 5.82 % |
| Last 5 Financial years | 3.60 | 30.44 | 11.83 % |
| Last 10 Financial years | 8.75 | 28.76 | 30.44 % |
| P/E (TTM) | NEG |
| P/E Before Unusual Items (TTM) | NEG |
| P/BV | 2.66 |
| Dividend Yield | - |
| Market Cap. (M) | 3,948.00 |
| Return on Average Assets | (0.51 %) |
| Return on Average Equity | (1.46 %) |
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}